Athletes subject to drug testing must not use these compounds
Consumers increasingly prefer low-volume nutritional formats designed for satiety support, digestive comfort, and balanced daily nutrient intake management
Diabetes Obes Metab 13(4):348356 Gasbjerg LS, Helsted MM, Hartmann B, Jensen MH, Gabe MBN, Sparre-Ulrich AH et al (2019) Separate and combined glucometabolic effects of endogenous glucose-dependent Insulinotropic polypeptide and glucagon-like peptide 1 in healthy individuals
Some studieswhich have faced methodological critiquessuggest that insulin glargine may increase the risk of breast cancer
In December, 1,300 cases were pending in the Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation
Individual results vary, and consistency is more important than starting intensity